Venture Capital

Governor Jim Doyle's 2007-09 budget proposal will include $2 million for a proposed venture capital center that seeks to connect entrepreneurs with sources of capital and serve as a point of entry for investors that want to deal in Wisconsin. The venture capital center, a...

Avolte Venture Partners, a venture capital fund announced last year, has reached its initial capital-raising goal and is ready to consider Midwestern and Wisconsin investments in life science and information technology. The fund intends to make 10 to 15 investments ranging from $1 million to...

It's not a done deal yet, but a Georgia stem cell company is contemplating a move to Wisconsin. Aruna Biomedical, which was spun out of research developed at the University of Georgia, will move to Wisconsin if it can find additional backing from angel investors....

With apologies to David Letterman, Yer Biotech Blues columnist Mike Rosen details the top 10 trends that made 2006 such a remarkable year in the “bio” sphere. His number one selection may bode well for the biofuels industry in Wisconsin and beyond....

Madison-based Venture Investors is one of three venture capital firms nationwide to receive money from a Michigan capital fund. The company plans to open a second office in Ann Arbor, putting it in a position to tap into two of the nation's largest research institutions....

Coastal investors are no longer parochial risk takers when it comes to putting their money where their healthcare is, and the Midwest is benefiting from the trend, according to a new report from the Cleveland-based BioEnterprise....

A modest income tax cut is among the legislative measures contained in Invest 2.0, the second generation economic development package introduced by a group of lawmakers led by State Sen. Ted Kanavas, R-Brookfield....

Wisconsin continues to move forward in attracting venture capital, but the pace of progress is still slow, according to a recent venture capital report. Despite a growing tech industry, the state captured less than one percent of total venture dollars invested....

Cytochroma, a Canadian biotechnology firm that plans to open a facility in Madison in 2007, has raised $21 million in venture capital to start clinical trials for its vitamin D products. The firm is managed by former employees of Bone Care International who are being...

Mirus Bio, a Madison biotechnology company, has entered into a milestone agreement with pharmaceutical giant Pfizer to develop gene suppression techniques for the development of drugs. The agreement will enable Mirus to further develop two platform technologies used to deliver nucleic acid to the bloodstream...